一般演題（口演）55 EGFR遺伝子変異陽性肺癌（基礎）

[O55-2] MUC1-C is a Common Target of Acquired Osimertinib Resistance in EGFR-Mutated NSCLC

^○原武 直紀^1,2, Bhattacharya Atrayee¹, 磯崎 英子³, 小副川 敦², Hata Aaron³, Kufe Donald¹ (1.Harvard Medical School, Dana-Farber Cancer Institute, 2.大分大学医学部呼吸器・乳腺外科学講座, 3.Harvard Medical School, Massachusetts General Hospital)